CS
ABMD

Candriam SCA’s Abiomed Inc ABMD Stock Holding History

Candriam SCA’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-9,786
Closed -$2.4M – 899
2022
Q3 		$2.4M Buy
9,786
+7,438
+317% +$2.01M 0.02% 550
2022
Q2 		$581K Buy
2,348
+80
+4% +$21.6K ﹤0.01% 711
2022
Q1 		$751K Buy
+2,268
New +$698K 0.01% 701
2021
Q3 		– Sell
-764
Closed -$238K – 926
2021
Q2 		$238K Sell
764
-2,470
-76% -$758K ﹤0.01% 829
2021
Q1 		$1.01M Hold
3,234
– – 0.01% 635
2020
Q4 		$1.05M Buy
3,234
+898
+38% +$248K 0.01% 647
2020
Q3 		$647K Sell
2,336
-855
-27% -$246K 0.01% 686
2020
Q2 		$771K Sell
3,191
-561
-15% -$113K 0.01% 643
2020
Q1 		$626K Hold
3,752
– – 0.01% 697
2019
Q4 		$640K Sell
3,752
-2,330
-38% -$432K 0.01% 714
2019
Q3 		$1.08M Buy
6,082
+1,661
+38% +$359K 0.01% 594
2019
Q2 		$1.15M Buy
4,421
+660
+18% +$175K 0.01% 629
2019
Q1 		$1.07M Buy
3,761
+737
+24% +$245K 0.01% 614
2018
Q4 		$983K Buy
3,024
+184
+6% +$63.9K 0.02% 587
2018
Q3 		$1.28M Buy
2,840
+147
+5% +$57.9K 0.02% 581
2018
Q2 		$1.1M Buy
+2,693
New +$976K 0.02% 592

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Candriam SCA's ABMD Position: Q4 2022 in Review

Candriam SCA sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 9,786 shares — an estimated $2.4M sold.

Candriam SCA first reported a position in ABMD in Q2 2018 and held it in 16 quarters. The position peaked at $2.4M in Q3 2022. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Candriam SCA reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Candriam SCA sold 9,786 Abiomed Inc shares in Q4 2022, an estimated $2.4M.
  • Candriam SCA first reported a position in Abiomed Inc in Q2 2018 and held it in 16 quarters.
  • Candriam SCA's Abiomed Inc position peaked at $2.4M in Q3 2022.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Candriam SCA's 13F filing for Q4 2022, filed 13 Feb 2023.